Katherine Hoadley

All papers authored by Katherine Hoadley

This paper was not found in any repository, but could be made available legally by the author.

2024 Ji-Eun Park

, Markia A. Smith

, Sarah C. Van Alsten

, Andrea Walens

, Di Wu

, Katherine A. Hoadley

, Melissa A. Troester

, Michael I. Love

Diffsig: Associating Risk Factors with Mutational Signatures

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Ian R. Sturgill, Jesse R. Raab, Katherine A. Hoadley

Expanded detection ofBAP1alterations in cancer and tumor type-specific expression score comparison

Upload

This paper is made freely available by the publisher.

Yifeng Shi, Linnea T. Olsson, Katherine A. Hoadley

, Benjamin C. Calhoun

, J. S. Marron

, Joseph Geradts, Marc Niethammer, Melissa A. Troester

Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study

Download from doi.org

Mattia Rediti

, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A. Hoadley

, Joel S. Parker

, Baljit Singh, Jordan D. Campbell, Karla V. Ballman, David W. Hillman

, Eric P. Winer, Sarra El-Abed, Martine Piccart

, Serena Di Cosimo

, William Fraser Symmans

and 7 other authors

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

Download from doi.org

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

, Jelmar Quist, Sarah Kernaghan, Lucy Kilburn, Roberto Salgado, Sherene Loi, Richard D. Kennedy, Ioannis Roxanis, Patrycja Gazinska, Sarah E. Pinder, Judith Bliss, Charles M. Perou and 4 other authors

Supplementary Figure S4 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Table S3 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Figure 5 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Figure 2 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Table S1 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Figure 1 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Table 1 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Figure S2 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Table S2 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Figure 4 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Data from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Table S4 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Figure S5 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Figure S3 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Supplementary Figure S1 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley

Figure 3 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Katherine Hoadley